Company Filing History:
2 out of 2 
1 out of 1 
1 out of 5 Years Active: 1998-2007
Title: The Innovative Works of Peter D. Rathjen
Introduction
Peter D. Rathjen, an accomplished inventor based in Blackwood, Australia, has made significant contributions to the field of xenotransplantation. With a total of two patents to his name, his groundbreaking work focuses on addressing the challenges associated with hyperacute rejection in human xenotransplantation.
Latest Patents
Rathjen's most recent patents detail innovative materials and methods for managing hyperacute rejection in human xenotransplantation. His work delves into the role of human pre-formed xenoantibodies in this rejection response, disclosing strategies for either removing or neutralizing these antibodies. Furthermore, he explores methods for reducing or eliminating the epitopes in donor organs that are recognized by such antibodies, which are created through the activity of the enzyme α-1,3 galactosyltransferase. His patents also detail the porcine gene responsible for α-1,3 galactosyltransferase, along with approaches for inactivating this gene in mammalian cells and embryos. Additionally, Rathjen has introduced a novel leukemia inhibitory factor (T-LIF), which plays a crucial role in the maintenance of embryonic stem cells and primordial germ cells in culture.
Career Highlights
Throughout his career, Rathjen has significantly impacted the biomedical field, particularly in xenotransplantation. He has worked at notable institutions, including St. Vincent's Hospital and Bresatch Limited, where he furthered his research and collaborations.
Collaborations
Peter D. Rathjen has collaborated with esteemed peers such as Martin J. Pearse and Allan J. Robins. Their combined expertise has contributed to the advancement of knowledge and innovation in biotechnology and medicine.
Conclusion
In summary, Peter D. Rathjen's innovative patents and collaborative efforts highlight his commitment to advancing the field of xenotransplantation. His work not only addresses critical issues in organ transplantation but also paves the way for future research and development in this vital area of medicine.